Symptoms of Hypercapnia
Hypercapnia primarily affects the central nervous system and cardiovascular system, causing symptoms ranging from excessive sleepiness and altered mental status to headache, confusion, and in severe cases, coma and cardiovascular compromise. 1
Clinical Presentation by Severity
Mild to Moderate Hypercapnia
The earliest and most common symptoms include:
- Excessive sleepiness or somnolence - Some patients become excessively sleepy with minimal elevation of PaCO2, while others remain alert despite much more severe hypercapnia 2
- Headache (from cerebral vasodilation)
- Confusion or altered mental status
- Dyspnea or breathlessness 2
Severe Hypercapnia
As PaCO2 rises further, symptoms progress to:
- Marked neurological impairment - mental and physical impairments that can be life-threatening 3
- Decreased level of consciousness
- Coma (in extreme cases)
- Cardiovascular effects including impaired cardiac contractility 2
Important Clinical Context
The tolerance of hypercapnia varies considerably between individuals 2. This variability means you cannot rely solely on PaCO2 levels to predict symptom severity - clinical assessment is paramount.
Disease-Specific Patterns
In neuromuscular disease (NMD) and chest wall deformity (CWD): Any elevation of PaCO2 may herald an impending crisis, even before respiratory acidosis develops. These patients have reduced respiratory reserve, and minor infections like coryza can trigger progressive hypercapnia over 24-72 hours 2.
In COPD: The degree of acidosis (pH) is more clinically important than the absolute degree of hypercapnia 2. Chronic hypercapnia is often inferred by elevated serum bicarbonate (>27 mmol/L) 4.
Associated Physiological Findings
Beyond symptoms, hypercapnia causes:
- Cerebral vasodilation leading to increased intracranial pressure 2
- Impaired venous return and increased right ventricular afterload 2
- In chronic cases: pulmonary hypertension, chronic hypoxemia, and polycythemia 2
Critical Pitfall
Do not wait for severe symptoms or respiratory acidosis to develop before intervening. NIV should be considered in any breathless or acutely unwell patient with NMD/CWD before respiratory acidosis develops 2. The presence of breathlessness with known risk factors (obesity, COPD, neuromuscular disease) warrants arterial blood gas measurement even if the patient appears relatively stable.